Serial 90081739
Live / Registered — Registered (as of 02 Apr 2024)
What this means for you
Registered since 02 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90081739
- Registration number
- 7347181
- Mark type
- Design / logo
- Filed
- 29 Jul 2020
- Published for opposition
- 22 Dec 2020
- Registered
- 02 Apr 2024
- Attorney of record
- Brian Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the prevention and treatment of neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders
- Class 042 — Scientific and technological services: Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; consultation related thereto
Owner
- ACADIA Pharmaceuticals, Inc., San Diego, CA, US
- ACADIA Pharmaceuticals, Inc., San Diego, CA, US
- ACADIA Pharmaceuticals, Inc., San Diego, CA, US
Prosecution history
- 12 Jun 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 12 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 24 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Feb 2024 — USE AMENDMENT FILED
- 05 Feb 2024 — TEAS STATEMENT OF USE RECEIVED
- 29 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2023 — SOU EXTENSION 5 GRANTED
- 20 Jul 2023 — SOU EXTENSION 5 FILED
- 28 Jul 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL